Artivion (AORT) CCO gets stock grant and sells shares to cover taxes

Rhea-AI Filing Summary

Artivion, Inc.’s Chief Commercial Officer John E. Davis reported a mix of stock compensation activity and related tax sales. He received a grant of 20,438 shares of restricted stock, which vest in equal thirds each year starting on the first anniversary of the grant date.

To cover tax withholding from vesting performance and restricted stock units, 5,848 shares were automatically sold in open-market transactions at prices of about $35.69 and $37.59 per share, described as non-discretionary “sell to cover” sales. After these transactions, Davis directly owns 209,306 shares of common stock.

Insider Trade Summary

Net Seller: 5,848 shares ($215,882)

Net Sell 3 txns

Insider Davis John E

Role Chief Commercial Officer

Sold 5,848 shs ($216K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,075	$35.693	$74K
Grant/Award	Common Stock	20,438	$0.00	--
Sale	Common Stock	3,773	$37.588	$142K

Holdings After Transaction: Common Stock — 188,868 shares (Direct)

Footnotes (1)

1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davis John E

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		S		3,773(1)	D	$37.588	190,943	D
Common Stock	02/24/2026		S		2,075(2)	D	$35.693	188,868	D
Common Stock	02/24/2026		A		20,438(3)	A	$0	209,306	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

2. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

3. Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ John E. Davis	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Artivion (AORT) executive John E. Davis report on this Form 4?

John E. Davis reported routine equity compensation activity, including a grant of 20,438 restricted shares and automatic “sell to cover” stock sales for tax withholding. These transactions adjust his direct holdings without indicating a discretionary change in his investment stance.

How many Artivion (AORT) shares did John E. Davis sell for taxes?

Davis reported automatic sales totaling 5,848 shares of Artivion common stock at prices around $35.69 and $37.59 per share. Footnotes describe these as non-discretionary “sell to cover” transactions executed solely to satisfy tax withholding obligations tied to vesting equity awards.

What equity award did John E. Davis receive from Artivion (AORT)?

He received 20,438 shares of restricted stock with an exercise price of $0.00. According to the disclosure, these shares vest 33 1/3% per year beginning on the first anniversary of the grant date, under Artivion’s Equity and Cash Incentive Plan.

How many Artivion (AORT) shares does John E. Davis own after these transactions?

Following the reported grant and related tax sales, Davis directly holds 209,306 shares of Artivion common stock. This updated ownership figure reflects both the new restricted stock award and the automatic “sell to cover” transactions executed to meet associated tax obligations.

Were John E. Davis’s Artivion (AORT) stock sales discretionary trades?

No. Footnotes explain the sales were executed upon vesting of performance and restricted stock units solely to cover tax withholding. They are described as “sell to cover” transactions and explicitly stated not to represent discretionary trading decisions by John E. Davis.